Ilika plc grants options under the Long Term Incentive Plan

Ilika

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has announced that on 28 February 2023 it granted options to Executive Directors and employees under the Long Term Incentive Plan approved by shareholders in 2018 and the EMI scheme.

LTIP

Ilika awarded nominal value options under the LTIP over 416,954 ordinary shares of 1p each in the Company to an Executive Director and options over a further 2,800 Ordinary Shares to employees. Each award vests on the achievement of certain performance targets over a three-year period. 

EMI option scheme

Ilika plc granted market value options over 802,248 ordinary shares of 1p each in the Company to an Executive Director and employees under the Company EMI option scheme.  EMI options vest on the achievement of certain performance targets over a three-year period. 

The awards are intended to align the incentives of the Executive Directors and other senior employees with the Company’s performance and outcomes for shareholders over the long term and to provide effective and attractive levels of reward, based on delivering strong performance in a fair and proportionate manner.

In total, options over 1,222,002 Ordinary Shares have been granted representing 0.77% of issued share capital.

Details of grants issued under the LTIP and EMI option scheme by each Executive Director are set out in the table below, together with the total number of Ordinary Shares each Executive Director holds under option and is interested in.

DirectorNumber of options grantedScheme under which options grantedTotal number of Options now heldPer cent. of issued share capital
Graeme Purdy416,954LTIP2,779,0671.76
Jason Stewart300,000EMI300,0000.19

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika Stereax batteries to feature at MEDevice Silicon Valley

Ilika will have its Stereax technology represented by Cirtec Medical at MEDevice Silicon Valley on 18 and 19 November 2026, providing further exposure to its medical device battery technology.

Ilika targets Europe’s next phase of solid-state battery development

Ilika is positioned around Europe’s push for next-generation solid-state batteries as manufacturers seek better performance and less dependence on Asian supply chains.

Ilika targets lighter EV battery packs

Ilika’s Goliath solid-state battery technology targets a higher cell-to-pack ratio by combining high-nickel NMC chemistry with a non-flammable solid electrolyte.

Ilika’s Graeme Purdy on Goliath, defence and Brompton progress (LON:IKA)

Ilika CEO Graeme Purdy discusses the completion of the PRIMED programme, improved consistency in Goliath battery performance, growing defence interest and progress with Brompton on e-bike battery applications.

Ilika appoints Robin Anderton-Brown as strategic defence advisor

Former UK Strategic Command Director of Capability Robin Anderton-Brown joins Ilika as a strategic advisor, supporting opportunities for its Goliath solid-state batteries in the defence sector.

Search